Displaying 2321 - 2340 of 38636
December 19, 2023
December 18, 2023
FTC Staff Report Details Key Takeaways from AI and Creative Fields Panel Discussion
Date
In a new report, Federal Trade Commission staff detailed key takeaways from an October 2023 public virtual roundtable that examined how generative artificial intelligence, tools that can generate...
Statement Regarding the Termination of John Muir’s Takeover of San Ramon Regional Medical Center from Tenet Healthcare
Date
The FTC and the State of California moved to dismiss their case challenging John Muir Health’s proposed deal to acquire sole ownership of San Ramon Regional Medical Center, LLC from current majority...
Statement Regarding Illumina’s Decision to Divest Grail
Date
Illumina, Inc. announced it would divest Grail, Inc. following a U.S. Court of Appeals for the Fifth Circuit decision that supported the Federal Trade Commission’s determination that the acquisition...
Federal Trade Commission and Justice Department Release 2023 Merger Guidelines
Date
Today, the Federal Trade Commission and the Justice Department jointly issued the 2023 Merger Guidelines, which describe factors and frameworks the agencies utilize when reviewing mergers and...
Case Timeline Item
IQVIA Holdings/Propel Media, In the Matter of (timeline item) - December 18, 2023
Date
File
Order Resetting Final Prehearing Conference
(671.55 KB)
Case Timeline Item
Illumina, Inc., and GRAIL, Inc., In the Matter of (timeline item) - December 18, 2023
Date
December 15, 2023
Case Timeline Item
Microsoft/Activision Blizzard, In the Matter of (timeline item) - December 15, 2023
Date
File
Case Timeline Item
IQVIA Holdings/Propel Media, In the Matter of (timeline item) - December 15, 2023
Date
File
December 14, 2023
FTC Approves Final Order Settling Horizon Therapeutics Acquisition Challenge
Date
The Federal Trade Commission today finalized a consent order that resolves potential competitive harm stemming from Amgen Inc.’s acquisition of Horizon Therapeutics plc. As part of a nationwide...
Case Timeline Item
IQVIA Holdings/Propel Media, In the Matter of (timeline item) - December 14, 2023
Date
File
Commission Order Granting Continuance
(751.86 KB)
Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - December 14, 2023
Date
File
Decision and Order (Public Version)
(4.57 MB)
Case Timeline Item
Luis Jorge Perez, In the Matter of (timeline item) - December 14, 2023
Date
File
Order Setting Briefing Schedule
(734.65 KB)
Case Timeline Item
Microsoft/Activision Blizzard, In the Matter of (timeline item) - December 14, 2023
Date
File
Joint Motion for Third Revised Scheduling Order
(762.12 KB)
December 13, 2023
Statement Regarding the Termination of Sanofi’s Proposed Acquisition of Maze Therapeutics’ Pompe Disease Drug
Date
Following Sanofi’s decision to terminate its proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s developmental drug to treat Pompe disease, the Federal Trade Commission moved to...
Case Timeline Item
Sanofi/Maze Therapeutics, Inc., In the Matter of (timeline item) - December 13, 2023
Date
File
Joint Motion to Dismiss Complaint
(1.55 MB)
Displaying 2321 - 2340 of 38636